Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prescribing Patterns for the Treatment of Bipolar Disorder in Pregnancy: A Retrospective Cohort Study.

Journal of clinical medicine·2025
Same author

The Nuances Surrounding Insulin Prescribing.

Clinical diabetes : a publication of the American Diabetes Association·2023
Same author

Ibrexafungerp in the Treatment of Vulvovaginal Candidiasis.

The Annals of pharmacotherapy·2022
Same author

Pharmacists' Perspectives on Prescribing and Expanding Access to Hormonal Contraception in Pharmacies in the United States.

Journal of pharmacy practice·2019
Same author

Evaluation of the impact of body mass index on warfarin requirements in hospitalized patients.

Therapeutic advances in cardiovascular disease·2018
Same author

Administration Rates of the Tdap Vaccine in Obstetric Patients.

The Annals of pharmacotherapy·2018

Related Experiment Video

Updated: Jun 9, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Pneumococcal vaccination process improvement in an acute care setting.

Abigail M Yancey1, Anne B Jundt, Kathryn J Nelson

  • 1Department of Pharmacy Practice, St Louis College of Pharmacy, St Louis, Missouri 63110-1088, USA. ayancey@stlcop.edu

Quality & Safety in Health Care
|August 28, 2010
PubMed
Summary

Pneumococcal vaccination rates in pneumonia patients significantly improved from 34.7% to over 90% using the Plan-Do-Study-Act model. This quality improvement initiative standardized care and optimized the vaccination process for better patient outcomes.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Experiment Videos

Last Updated: Jun 9, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Area of Science:

  • Healthcare Quality Improvement
  • Vaccinology
  • Infectious Disease Prevention

Background:

  • Pneumococcal vaccination is underutilized despite being a 21st-century standard of care.
  • Healthcare organizations aim to increase pneumococcal vaccine administration before hospital discharge.
  • SSM St Mary's Health Center addressed a low vaccination rate of 34.7%.

Purpose of the Study:

  • To improve the underutilized pneumococcal vaccination rate among hospitalised pneumonia patients.
  • To implement and monitor process changes using a quality improvement model.
  • To achieve a vaccination rate exceeding established benchmarks.

Main Methods:

  • Utilized the Plan-Do-Study-Act (PDSA) improvement model for process changes.
  • Focused on key steps: assessment, ordering, obtaining, and administering the vaccine.
  • Implemented a concurrent review process and tracked vaccination rates according to national guidelines.

Main Results:

  • The pneumococcal vaccination rate for pneumonia patients increased incrementally over two years.
  • The vaccination rate improved from an initial 34.7% to consistently exceed 90%.
  • Demonstrated successful implementation of a quality initiative to enhance vaccine uptake.

Conclusions:

  • The Plan-Do-Study-Act model facilitates continuous improvement in vaccination processes.
  • Multiple PDSA cycles are essential for standardizing the vaccination process and optimizing workflow.
  • Sustained improvements in pneumococcal vaccination rates are achievable through systematic quality initiatives.